PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis

被引:115
|
作者
Pende, D
Bottino, C
Castriconi, R
Cantoni, C
Marcenaro, S
Rivera, P
Spaggiari, GM
Dondero, A
Carnemolla, B
Reymond, N
Mingari, MC
Lopez, M
Moretta, L
Moretta, A
机构
[1] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[2] Ist Giannina Gaslini, I-16148 Genoa, Italy
[3] Univ Genoa, DIMES, I-16132 Genoa, Italy
[4] Univ Genoa, DOBIG, I-16132 Genoa, Italy
[5] Ctr Eccellenza Ric Biomed, I-16132 Genoa, Italy
[6] INSERM, U 119, Inst Biol Canc & Immunol, F-13009 Marseille, France
关键词
natural killer cells; tumors; activating receptors; cellular ligands;
D O I
10.1016/j.molimm.2004.07.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The capability of NK lymphocytes to kill tumor cells depends on different receptors/ligands interactions. In order to identify the cellular ligands recognized by "orphan" triggering receptors, mice were immunized with NK susceptible target cells. mAbs were selected that inhibited NK cytotoxicity and recognized two different molecules of 70 and 60-65 kDa. Tryptic digestion and mass spectra analysis of purified proteins identified these molecules as PVR and Nectin-2, respectively. PVR-Fc and Nectin-2-Fc chimeric molecules stained COS-7 cells expressing the DNAM-1 activating receptor and conversely, PVR and Nectin-2 CHO-K cell transfectants were stained by DNAM-1-Fc. Thus, both PVR and Nectin-2 represent specific ligands for DNAM-1. Importantly, the specific interaction between DNAM- I (in NK cells) and PVR or Nectin-2 (in target cells) enhanced the NK-mediated lysis of tumor cells that was downregulated by mAb-mediated masking of the receptor or its ligands. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 43 条
  • [31] Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia
    Kaito, Yuta
    Sugimoto, Emi
    Nakamura, Fumi
    Tsukune, Yutaka
    Sasaki, Makoto
    Yui, Shunsuke
    Yamaguchi, Hiroki
    Goyama, Susumu
    Nannya, Yasuhito
    Mitani, Kinuko
    Tamura, Hideto
    Imai, Yoichi
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1107 - 1120
  • [32] Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines
    Grossman, Lisa
    Chang, Chris
    Dai, Joanne
    Nikitin, Pavel A.
    Jima, Dereje D.
    Dave, Sandeep S.
    Luftig, Micah A.
    MSPHERE, 2017, 2 (06):
  • [33] Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells
    Grauwet, Korneel
    Cantoni, Claudia
    Parodi, Monica
    De Maria, Andrea
    Devriendt, Bert
    Pende, Daniela
    Moretta, Lorenzo
    Vitale, Massimo
    Favoreel, Herman W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (45) : 16118 - 16123
  • [34] The CD226/CD155 Interaction Regulates the Proinflammatory (Th1/Th17)/Anti-Inflammatory (Th2) Balance in Humans
    Lozano, Ester
    Joller, Nicole
    Cao, Yonghao
    Kuchroo, Vijay K.
    Hafler, David A.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (07): : 3673 - 3680
  • [35] Epstein-Barr virus induces adhesion molecule CD226 (DNAM-1) expression during primary B cell transformation into lymphoblastoid cell lines
    Lisa V Grossman
    Pavel A Nikitin
    Sandeep Dave
    Jason P Tourigny
    Micah A Luftig
    Infectious Agents and Cancer, 7 (Suppl 1)
  • [36] Impaired DNAM-1/CD155 interaction in MS disrupts NK-mediated immune regulation of T-cell activity and is reconstituted by therapeutic modulation of the IL-2 receptor
    Gross, C. C.
    Schulte-Mecklenbeck, A.
    Ruenzi, A.
    Kuhlmann, T.
    Posevitz-Fejfar, A.
    Schwab, N.
    Schneider-Hohendorf, T.
    Held, K.
    Konjevic, M.
    Dornmair, K.
    Hohlfeld, R.
    Elkins, J.
    Ziemssen, T.
    Meuth, S. G.
    Wiendl, H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 803 - 804
  • [37] Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
    Weulersse, Marianne
    Asrir, Assia
    Pichler, Andrea C.
    Lemaitre, Lea
    Braun, Matthias
    Carrie, Nadege
    Joubert, Marie-Veronique
    Le Moine, Marie
    Do Souto, Laura
    Gaud, Guillaume
    Das, Indrajit
    Brauns, Elisa
    Scarlata, Clara M.
    Morandi, Elena
    Sundarrajan, Ashmitha
    Cuisinier, Marine
    Buisson, Laure
    Maheo, Sabrina
    Kassem, Sahar
    Agesta, Arantxa
    Peres, Michael
    Verhoeyen, Els
    Martinez, Alejandra
    Mazieres, Julien
    Dupre, Loic
    Gossye, Thomas
    Pancaldi, Vera
    Guillerey, Camille
    Ayyoub, Maha
    Dejean, Anne S.
    Saoudi, Abdelhadi
    Goriely, Stanislas
    Avet-Loiseau, Herve
    Bald, Tobias
    Smyth, Mark J.
    Martinet, Ludovic
    IMMUNITY, 2020, 53 (04) : 824 - +
  • [38] DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells
    Toutirais, Olivier
    Cabillic, Florian
    Le Friec, Gaelle
    Salot, Samuel
    Loyer, Pascal
    Le Gallo, Matthieu
    Desille, Mireille
    de La Pintiere, Cecile Thomas
    Daniel, Pascale
    Bouet, Francoise
    Catros, Veronique
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (05) : 1361 - 1368
  • [39] Cancer related fibroblasts (CAFs) control killer activity of natural killer cell through the poliovirus receptor (PVR: CD155) and have an important role for tumor expansion
    Inoue, Tomoko
    Kawana, Kei
    Adachi, Katsuyuki
    Taguchi, Ayumi
    Nagamatsu, Ken
    Sato, Masakazu
    Yoshida, Mitsuyo
    Takahashi, Juri
    Fujimoto, Asaha
    Kamoto, Hiroe
    Yamashita, Aki
    Nagasaka, Kazunori
    Osuga, Yutaka
    Fujii, Tomoyuki
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2015, 112 : 129 - 129
  • [40] Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression
    Pignoloni, Benedetta
    Fionda, Cinzia
    Dell'Oste, Valentina
    Luganini, Anna
    Cippitelli, Marco
    Zingoni, Alessandra
    Landolfo, Santo
    Gribaudo, Giorgio
    Santoni, Angela
    Cerboni, Cristina
    JOURNAL OF IMMUNOLOGY, 2016, 197 (10): : 4066 - 4078